Back to Search
Start Over
Novel GAA sequence variant c.1211 A>G reduces enzyme activity but not protein expression in infantile and adult onset Pompe disease.
- Source :
-
Gene [Gene] 2014 Mar 01; Vol. 537 (1), pp. 41-5. Date of Electronic Publication: 2013 Dec 30. - Publication Year :
- 2014
-
Abstract
- Pompe disease is a clinically and genetically heterogeneous autosomal recessive disorder caused by lysosomal acid α-glucosidase (GAA) deficiency. We report on two affected members of a non-consanguineous Caucasian family, including a classical infantile-onset patient with severe cardiomyopathy (IO) and his paternal grandmother with the adult-onset (AO) form. Two compound heterozygous sequence variants of the GAA gene were identified in each patient by mutation analyses (IO=c.1211A>G and c.1798C>T; AO=c.1211A>G and c.692+5G>T). For this study, the biochemical phenotype resulting from the missense mutation c.1211A>G in exon 8, which converts a highly conserved aspartate to glycine (p.Asp404Gly), was of specific interest because it had not been reported previously. Western blotting revealed a robust expression of all GAA isoforms in quadriceps muscle of both patients (fully CRIM positive), while enzymatic activity was 3.6% (IO) and 6.6% (AO) of normal controls. To further validate these findings, the c.1211A>G sequence variant was introduced in wild type GAA cDNA and over-expressed in HEK293T cells. Site-directed mutagenesis analyses confirmed that the mutation does not affect processing or expression of GAA protein, but rather impairs enzyme function. Similar results were reported for c.1798C>T (p.Arg600Cys), which further supports the biochemical phenotype observed in IO. The third mutation (c.692+5G>T, in intron 3) was predicted to affect normal splicing of the GAA mRNA, and qPCR indeed verified a 4-fold lower mRNA expression in AO. It is concluded that the novel sequence variant c.1211A>G results in full CRIM but significantly lower GAA activity, which in combination with c.1798C>T leads to infantile-onset Pompe disease. We surmise that the difference in disease severity between the two family members in this study is due to a milder effect of the intronic mutation c.692+5G>T (vs. c.1798C>T) on phenotype, partially preserving GAA activity and delaying onset in the proband (paternal grandmother).<br /> (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Subjects :
- Age of Onset
Case-Control Studies
Female
Glycogen Storage Disease Type II enzymology
Glycogen Storage Disease Type II epidemiology
HEK293 Cells
Humans
Infant
Male
Middle Aged
Mutation
Pedigree
Phenotype
Pregnancy
Quadriceps Muscle enzymology
RNA Splicing
Reference Values
Glucan 1,4-alpha-Glucosidase genetics
Glucan 1,4-alpha-Glucosidase metabolism
Glycogen Storage Disease Type II genetics
Mutation, Missense
Subjects
Details
- Language :
- English
- ISSN :
- 1879-0038
- Volume :
- 537
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Gene
- Publication Type :
- Academic Journal
- Accession number :
- 24384324
- Full Text :
- https://doi.org/10.1016/j.gene.2013.12.033